The 9 analysts offering 1 year price forecasts for ONCO3 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to ONCO3 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ONCO3 EPS for the last quarter is −0.02 BRL despite the estimation of 0.07 BRL. In the next quarter EPS is expected to reach 0.08 BRL. Track more of ONCOCLINICASON NM financials and stay on top of what is up with the company.
In the next quarter ONCOCLINICASON NM revenue is expected to reach 1.66 B BRL. Check out ONCOCLINICASON NM revenue and earnings and make informed decisions.
According to analysts, ONCO3 price target is 7.62 BRL with a max estimate of 13.00 BRL and a min estimate of 5.50 BRL. Check if this forecast comes true in a year, meanwhile watch ONCOCLINICASON NM stock price chart and keep track of the current situation with ONCO3 news and stock market news.
We've gathered opinions of 9 analysts rating ONCO3 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.